OPTN Stock Summary and Trading Ideas (Optinose | NASDAQ:OPTN)

OptiNose Inc is a specialty pharmaceutical company that focuses on the development and commercialization of products for patients treated by ear, nose, and throat, and allergy specialists. Its product includes XHANCE (fluticasone propionate) nasal spray, 93 micrograms, a therapeutic utilizing its proprietary Exhalation Delivery System (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps. The XHANCE is able to deliver medication to the primary site of inflammation high and deep in the nasal passages in regions not adequately reached by intranasal steroids.

Optinose trades on the NASDAQ stock market under the symbol OPTN.

As of April 24, 2024, OPTN stock price declined to $0.93 with 566,619 million shares trading.

OPTN has a beta of 0.68, meaning it tends to be less sensitive to market movements. OPTN has a correlation of 0.01 to the broad based SPY ETF.

OPTN has a market cap of $104.24 million. This is considered a Micro Cap stock.

Last quarter Optinose reported $20 million in Revenue and -$.09 earnings per share. This beat revenue expectation by $635,000 and met earnings estimates .

In the last 3 years, OPTN stock traded as high as $4.30 and as low as $.86.

The top ETF exchange traded funds that OPTN belongs to (by Net Assets): VTI, IWM, VXF, IWO, VTWO.

OPTN has underperformed the market in the last year with a price return of -50.5% while the SPY ETF gained +24.2%. OPTN has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -34.8% and -24.8%, respectively, while the SPY returned +4.6% and -2.7%, respectively.

OPTN support price is $.91 and resistance is $1.02 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that OPTN stock will trade within this expected range on the day.